| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
2013 annual congress of the European Respiratory Society
|
Akkermans, Rebecca
|
|
2013
|
1 |
8 |
p. 594-595
2 p.
|
artikel
|
| 2 |
Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial
|
Davies, Jane
|
|
2013
|
1 |
8 |
p. 630-638
9 p.
|
artikel
|
| 3 |
Azithromycin in bronchiectasis: evidence in children?
|
Bilton, Diana
|
|
2013
|
1 |
8 |
p. 587-589
3 p.
|
artikel
|
| 4 |
Corrections
|
|
|
2013
|
1 |
8 |
p. 592-
1 p.
|
artikel
|
| 5 |
Corrections
|
|
|
2013
|
1 |
8 |
p. 592-
1 p.
|
artikel
|
| 6 |
Corrections
|
|
|
2013
|
1 |
8 |
p. 592-
1 p.
|
artikel
|
| 7 |
Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial
|
Hermans, Greet
|
|
2013
|
1 |
8 |
p. 621-629
9 p.
|
artikel
|
| 8 |
Global differences in lung function by region (PURE): an international, community-based prospective study
|
Duong, MyLinh
|
|
2013
|
1 |
8 |
p. 599-609
11 p.
|
artikel
|
| 9 |
Hope for haloperidol in delirium
|
van den Boogaard, Mark
|
|
2013
|
1 |
8 |
p. e27-
1 p.
|
artikel
|
| 10 |
Jane Carter: at the frontline of tuberculosis care
|
Kirby, Tony
|
|
2013
|
1 |
8 |
p. 597-
1 p.
|
artikel
|
| 11 |
KBR appeals $85 million sodium dichromate verdict
|
Furlow, Bryant
|
|
2013
|
1 |
8 |
p. 593-
1 p.
|
artikel
|
| 12 |
Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial
|
Valery, Patricia C
|
|
2013
|
1 |
8 |
p. 610-620
11 p.
|
artikel
|
| 13 |
Mass gatherings and respiratory disease
|
Burki, Talha Khan
|
|
2013
|
1 |
8 |
p. 598-
1 p.
|
artikel
|
| 14 |
Muscle weakness and nutrition in critical illness: matching nutrient supply and use
|
Latronico, Nicola
|
|
2013
|
1 |
8 |
p. 589-590
2 p.
|
artikel
|
| 15 |
Mutation-specific therapy in cystic fibrosis: the earlier, the better
|
Tümmler, Burkhard
|
|
2013
|
1 |
8 |
p. 591-592
2 p.
|
artikel
|
| 16 |
New statistical model raises hope of better lung nodule management
|
Maurice, John
|
|
2013
|
1 |
8 |
p. 596-
1 p.
|
artikel
|
| 17 |
New treatments for severe treatment-resistant asthma: targeting the right patient
|
Chung, Kian Fan
|
|
2013
|
1 |
8 |
p. 639-652
14 p.
|
artikel
|
| 18 |
Prophylactic haloperidol: too early to lose hope
|
Viana, Marina Verçoza
|
|
2013
|
1 |
8 |
p. e27-e28
nvt p.
|
artikel
|
| 19 |
Prophylactic haloperidol: too early to lose hope – Author's reply
|
Page, Valerie J
|
|
2013
|
1 |
8 |
p. e28-
1 p.
|
artikel
|
| 20 |
Rates of lung disease in Europe: an uncomfortable equilibrium
|
The Lancet Respiratory Medicine,
|
|
2013
|
1 |
8 |
p. 585-
1 p.
|
artikel
|
| 21 |
Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia
|
Singanayagam, Aran
|
|
2013
|
1 |
8 |
p. 653-662
10 p.
|
artikel
|
| 22 |
What are the causes of global differences in lung function?
|
Yammine, Sophie
|
|
2013
|
1 |
8 |
p. 586-587
2 p.
|
artikel
|
Tijdschrift beschrijving